Mizuho raised the firm’s price target on Herbalife (HLF) to $9 from $8 and keeps a Neutral rating on the shares. The company’s Q3 adjusted EBITDA beat on benefits from savings while global volume points remained soft, the analyst tells investors in a research note.
Pick the best stocks and maximize your portfolio:
- Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!
- Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks